How Healthcare Professionals Give a Thiamine Injection

Thiamine injections are given either intravenously (into a vein) or intramuscularly (into a muscle), depending on how urgently the body needs the vitamin and how well the patient can absorb it through the gut. In emergency settings like suspected Wernicke encephalopathy, the intravenous route is standard because it delivers thiamine directly into the bloodstream within minutes. The process itself is straightforward, but the clinical decisions around it, from choosing the right route and dose to timing it alongside other treatments, involve more nuance than many people expect.

Why Injection Instead of a Pill

Thiamine taken by mouth has surprisingly poor absorption. Studies measuring how much of an oral dose actually reaches the bloodstream put the figure at roughly 5%, with estimates ranging from about 3.7% to 5.3%.¹ That means if you swallow a 100 mg thiamine tablet, only about 5 mg makes it into your blood. For someone who is mildly low on thiamine and eating normally, oral supplements can still work because the body only needs small amounts each day, and oral doses given over a week can gradually build blood levels that approach what injections achieve.²

But in situations where thiamine deficiency is severe or the gut simply cannot absorb the vitamin properly, oral supplementation is not fast or reliable enough. Chronic alcohol use, for example, physically damages the intestinal transport system that pulls thiamine from food into the body. Research in animal models has shown that chronic alcohol exposure reduces the expression of the main thiamine transporter in the gut lining, meaning the intestine loses some of its ability to grab the vitamin even when it is present.³ On top of that, people with alcohol use disorder often eat poorly, store thiamine less effectively in the liver, and may have trouble converting thiamine into its active form.⁴ When all these factors stack up, bypassing the gut entirely with an injection is the only way to get therapeutic levels into the bloodstream quickly.

What Thiamine Does Once It Gets In

Once thiamine enters the blood, the body converts most of it into its active form, called thiamine diphosphate (sometimes referred to as thiamine pyrophosphate). About 90% of the thiamine in your body exists in this active form at any given time.⁵ This active form works as a helper molecule for several enzymes involved in turning food into energy and maintaining the nervous system. It plays a role in the chain of reactions that converts glucose into usable fuel for cells, and it supports enzymes in pathways that metabolize fats and branched-chain amino acids.⁶

This is why severe deficiency hits the brain so hard. The brain runs almost exclusively on glucose, and without enough active thiamine, it cannot efficiently convert that glucose into energy. The result can be Wernicke encephalopathy, a neurological emergency marked by confusion, problems with eye movements, and unsteadiness on the feet. Left untreated, it can progress to permanent brain damage. The speed of injection delivery matters here because every hour of delay means more time the brain is starving for the energy it cannot produce.

Intravenous Administration

For acute deficiency or suspected Wernicke encephalopathy, the intravenous route is preferred. The thiamine is typically diluted in normal saline and infused over a controlled period rather than pushed rapidly. One commonly used formulation in the UK, called Pabrinex, contains 250 mg of thiamine hydrochloride per pair of vials along with several other B vitamins and ascorbic acid, diluted into 100 mL of normal saline and infused over 30 minutes.⁷ The slow infusion rate is deliberate: it reduces the risk of side effects compared with a rapid bolus push, particularly for formulations that contain multiple vitamins.

In practice, a nurse or physician typically inserts an IV line (or uses an existing one if the patient already has IV access), connects the thiamine solution, and monitors the patient during the infusion. Vital signs are usually checked before, during, and after. The monitoring period matters because, although rare, allergic reactions are possible with parenteral thiamine and tend to happen during or shortly after the infusion.

After an IV dose, unphosphorylated thiamine spikes rapidly in the blood and then falls back toward baseline over about 12 hours, with a half-life of roughly 96 minutes.¹ This relatively quick clearance is one reason why treatment protocols typically call for multiple doses per day over several days rather than a single large infusion.

Intramuscular Injection

When IV access is difficult or unavailable, thiamine can be given intramuscularly. This is common in outpatient settings, emergency departments where a patient’s veins are hard to access, or situations where a quick single dose is needed before a full IV protocol can be set up. The injection is given into a large muscle, most often the upper outer quadrant of the buttock (dorsogluteal site) or the side of the hip (ventrogluteal site).

Absorption from an IM injection is slower than IV but still far faster and more complete than oral. The thiamine diffuses from the muscle tissue into surrounding blood vessels over the course of minutes to an hour, making it a reasonable middle ground when the situation is urgent but not immediately life-threatening.

Intramuscular thiamine injections can sting. The solution has a low pH, and the volume injected sometimes causes local discomfort. A systematic review of techniques for reducing intramuscular injection pain found that applying manual pressure to the injection site before the needle goes in meaningfully reduces the pain. Rhythmic tapping on the area also helped. Additionally, using the ventrogluteal site (the side of the hip) caused less pain than the traditional dorsogluteal site (the upper buttock).⁸ These are small practical details, but they matter for patients who may need repeated injections over several days.

Dosing for Wernicke Encephalopathy and Related Conditions

The dose of thiamine used in clinical practice varies considerably depending on the severity of deficiency and the guidelines a hospital follows. For suspected Wernicke encephalopathy, many expert recommendations now call for high-dose parenteral thiamine, typically 500 mg or more given intravenously three times daily for two to three days. A case series examining patients treated with at least 500 mg of IV thiamine found that roughly three out of four patients showed improvement or complete resolution of symptoms after a median of three days of treatment.⁹ The treatment appeared safe, with no serious adverse effects linked to the high doses.

Despite this, the evidence base for pinning down the ideal dose is thinner than you might expect. A randomized controlled trial comparing different thiamine dosing regimens in patients at risk for Wernicke-Korsakoff syndrome found no significant differences between the dose groups on measures of cognitive or neurological function.¹⁰ The researchers noted that the trial was complicated by the real-world messiness of treating severely ill patients with multiple health problems. Still, the overall trend in the literature favors high-dose regimens for neuropsychiatric presentations.¹¹

For prophylaxis, meaning prevention in at-risk patients who do not yet show symptoms, lower doses are typical. A hospitalized patient with alcohol use disorder who is otherwise stable might receive 100 to 250 mg of thiamine intramuscularly or intravenously once daily for several days. The clinical judgment here revolves around how malnourished the patient appears, how long they have been drinking, and whether other risk factors for deficiency are present.

The Glucose Timing Question

One of the most discussed aspects of thiamine injection in emergency medicine is when to give it relative to glucose. A patient arriving in the emergency department with altered mental status might be hypoglycemic, and the instinct is to give glucose immediately. But if that patient is also severely thiamine-deficient, flooding the body with glucose without first providing thiamine can theoretically worsen things. Glucose metabolism depends on thiamine-dependent enzymes, and a sudden surge of glucose in a thiamine-depleted brain can exhaust the last remaining stores of the vitamin, pushing a borderline situation into full-blown Wernicke encephalopathy.

A literature review examining this question found mounting case evidence that prolonged glucose supplementation without the addition of thiamine can indeed be a risk factor for developing Wernicke encephalopathy.¹² In practice, many emergency departments now give thiamine either before or simultaneously with glucose in patients at risk, rather than waiting. If a patient is critically hypoglycemic, though, correcting the glucose cannot be delayed; in that case, the thiamine goes in at the same time or as soon as possible afterward. The key takeaway for clinicians is that thiamine should not be forgotten or deferred in any patient who might be deficient and is receiving IV glucose.

Safety and Allergic Reactions

Parenteral thiamine has a reputation in some clinical circles for causing allergic reactions, and this concern has historically led to under-treatment. Some providers have been hesitant to give high-dose IV thiamine out of fear of anaphylaxis. The actual risk, however, is extremely small. An analysis of adverse reaction reports found a total of 10 anaphylactic reactions to the Pabrinex formulation across between roughly 5.4 and 6.7 million patient-days of treatment.¹³ That works out to an anaphylaxis rate lower than many commonly used drugs.

Milder reactions are somewhat more common but still infrequent. These can include local irritation at the injection site, mild itching, or a feeling of warmth during infusion. True anaphylaxis, with breathing difficulty, swelling, and cardiovascular collapse, is vanishingly rare. The consensus among specialists is that the risk of untreated Wernicke encephalopathy, which has a mortality rate that can reach double digits, vastly outweighs the tiny risk of a serious allergic reaction. Facilities should have standard anaphylaxis kits available during infusion as a precaution, but fear of allergy should not be a reason to withhold treatment.

Handling and Light Sensitivity

Thiamine is a photosensitive compound, meaning it breaks down when exposed to light. This has practical consequences for how the solution is stored and administered. Vials should be kept in their packaging until ready to use, and once the solution is mixed for IV infusion, it should be protected from direct light during administration.¹⁴ In hospitals, this sometimes means covering the IV bag with an opaque sleeve or running the infusion in a dimly lit area. Failure to protect the solution from light can reduce the amount of active thiamine the patient actually receives, which is especially concerning when precision matters in high-dose treatment for neurological emergencies.

Temperature also matters. Most formulations are stored at room temperature or in a refrigerator, depending on the manufacturer’s instructions. Once diluted into saline, the solution is generally intended for immediate or near-immediate use. Pharmacy departments in hospitals typically prepare the infusion shortly before it is needed, and nurses are trained not to hang the bag for extended periods before starting the drip.

Thiamine Deficiency Beyond Alcohol Use Disorder

While alcohol-related thiamine deficiency gets the most attention, injections are used in other populations too. Pregnant women with hyperemesis gravidarum, the severe form of morning sickness involving persistent vomiting and weight loss, can develop dangerously low thiamine levels. Because these patients often cannot keep food or oral supplements down for weeks, the gut route is unreliable, and IV thiamine becomes necessary. Case reports have documented Wernicke encephalopathy in pregnant women with severe hyperemesis, presenting with confusion, eye movement abnormalities, and unsteadiness.¹⁵ A review of such cases also noted that the classic triad of Wernicke symptoms does not always appear in full, and some patients present with atypical features that can delay diagnosis.¹⁶

Patients on long-term parenteral nutrition (IV feeding) are another group that needs thiamine monitoring and supplementation. So are people recovering from bariatric surgery, those with severe malabsorption conditions, and critically ill patients in intensive care units. In neonates, refeeding syndrome following intrauterine growth restriction has been corrected with high-dose thiamine supplementation.¹⁷ The common thread across all these groups is that when the gut cannot be trusted to absorb enough thiamine, injection is the safest way to replete it.

What Recovery Looks Like After Treatment

One of the more reassuring aspects of thiamine injection therapy is how quickly some symptoms can improve. In Wernicke encephalopathy, eye movement problems are often the first to resolve, sometimes within hours of the initial dose. Confusion typically takes longer, improving over days. Unsteadiness and gait problems can take weeks or longer to fully resolve, and in some patients, the ataxia never completely goes away, especially if treatment was delayed.

A case report describing a patient with prolonged Wernicke encephalopathy who was treated with extended high-dose thiamine showed that even late treatment can produce gradual improvement, though recovery was slow and incomplete.¹⁸ The lesson for healthcare professionals is that early and aggressive treatment produces the best outcomes. Once brain tissue has been damaged beyond a certain point, no amount of thiamine will fully reverse it. The injection itself is technically simple; the challenge is recognizing the deficiency early enough to prevent irreversible harm.

Magnesium and the Role of Co-factors

Thiamine does not work in isolation. Magnesium is required for the enzyme that converts thiamine into its active diphosphate form. A patient can receive large doses of thiamine by injection, but if their magnesium levels are severely low, the body may struggle to activate the vitamin. This is relevant because many of the same populations at risk for thiamine deficiency, particularly people with alcohol use disorder, are also commonly deficient in magnesium. Clinical protocols for treating suspected Wernicke encephalopathy increasingly include magnesium checks and supplementation alongside thiamine, reflecting the recognition that fixing one deficiency without addressing the other may limit how well the treatment works.⁷

In practice, this means that the healthcare professional administering a thiamine injection may also be drawing blood for a magnesium level or starting a magnesium sulfate infusion simultaneously. The two treatments often run in parallel, and thinking of thiamine repletion as a stand-alone intervention misses part of the clinical picture.